NIH's Role In Sustaining the U.S. Economy | 2023 Update Now Available
Announcing Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
Read UMR's Dec. 8 Letter to Congressional Leadership on the Urgent Need to Pass an FY23 Omnibus Appropriations Bill
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong
Privacy Policy © 2023 United For Medical Research. All Rights Reserved.

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that the BD MAX™ Respiratory Viral Panel (RVP), a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus (RSV), has been CE marked to the IVD directive 98/79/EC.